Everyday Health on MSN

IVIg to SCIg: Considerations when switching immunoglobulin therapies for primary immunodeficiency

Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, costs, and how each impacts quality of life.
Healio

C1 inhibitor prevents adverse events from immunoglobulin replacement therapy

Please provide your email address to receive an email when new articles are posted on . Immunoglobulin replacement therapy triggered severe neuropathy. A 4,200 U dose ...